Guggenheim Capital LLC lowered its stake in M.D.C. Holdings, Inc. (NYSE:MDC – Get Rating) by 9.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 22,999 shares of the construction company’s stock after selling 2,534 shares during the quarter. Guggenheim Capital LLC’s holdings in M.D.C. were worth $630,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also added to or reduced their stakes in MDC. Raymond James & Associates boosted its stake in M.D.C. by 47.2% in the 3rd quarter. Raymond James & Associates now owns 905,190 shares of the construction company’s stock worth $24,820,000 after purchasing an additional 290,390 shares during the period. Dimensional Fund Advisors LP raised its holdings in shares of M.D.C. by 5.4% in the 3rd quarter. Dimensional Fund Advisors LP now owns 4,807,068 shares of the construction company’s stock valued at $131,813,000 after acquiring an additional 247,697 shares in the last quarter. River Road Asset Management LLC purchased a new stake in shares of M.D.C. in the 3rd quarter valued at about $4,391,000. Invesco Ltd. raised its holdings in shares of M.D.C. by 69.5% in the 1st quarter. Invesco Ltd. now owns 371,508 shares of the construction company’s stock valued at $14,057,000 after acquiring an additional 152,388 shares in the last quarter. Finally, Heartland Advisors Inc. purchased a new stake in shares of M.D.C. in the 3rd quarter valued at about $3,932,000. Institutional investors own 82.21% of the company’s stock.
M.D.C. Price Performance
Shares of MDC stock opened at $36.26 on Friday. The company has a debt-to-equity ratio of 0.54, a quick ratio of 2.84 and a current ratio of 8.58. M.D.C. Holdings, Inc. has a fifty-two week low of $27.04 and a fifty-two week high of $43.88. The firm has a market cap of $2.65 billion, a P/E ratio of 4.73 and a beta of 1.36. The business’s 50 day moving average price is $36.65 and its 200-day moving average price is $32.78.
M.D.C. Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 22nd. Stockholders of record on Wednesday, February 8th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 5.52%. The ex-dividend date of this dividend was Tuesday, February 7th. M.D.C.’s dividend payout ratio is currently 26.08%.
Wall Street Analyst Weigh In
MDC has been the topic of several recent analyst reports. StockNews.com raised M.D.C. from a “sell” rating to a “hold” rating in a report on Friday, December 16th. Wedbush reissued a “neutral” rating on shares of M.D.C. in a report on Tuesday, February 7th. Finally, JPMorgan Chase & Co. decreased their price objective on M.D.C. from $30.50 to $27.50 and set an “underweight” rating on the stock in a report on Monday. Two research analysts have rated the stock with a sell rating and three have issued a hold rating to the company’s stock. According to data from MarketBeat.com, M.D.C. presently has an average rating of “Hold” and an average price target of $27.50.
Insider Transactions at M.D.C.
In other news, Director Herbert T. Buchwald sold 8,349 shares of the business’s stock in a transaction on Wednesday, March 8th. The stock was sold at an average price of $36.20, for a total value of $302,233.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, Director David E. Blackford sold 3,000 shares of the company’s stock in a transaction that occurred on Wednesday, February 8th. The stock was sold at an average price of $38.35, for a total transaction of $115,050.00. Following the transaction, the director now owns 25,087 shares of the company’s stock, valued at $962,086.45. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Herbert T. Buchwald sold 8,349 shares of the company’s stock in a transaction on Wednesday, March 8th. The shares were sold at an average price of $36.20, for a total value of $302,233.80. The disclosure for this sale can be found here. Insiders sold 15,849 shares of company stock worth $582,299 over the last quarter. 23.30% of the stock is currently owned by insiders.
M.DC Holdings, Inc engages in proving homebuilding and financial services. It operates through the following business segments: West, Mountain, and East. The West segment includes operations in Arizona, California, Nevada, New Mexico, Oregon, Texas, and Washington. The Mountain segment refers to the operations in Colorado, Idaho, and Utah.
- Get a free copy of the StockNews.com research report on M.D.C. (MDC)
- Fossil Group: Should You Bet On Consumer Discretionary In 2023?
- BJ’s Wholesale Club Stock Moves Higher After Strong Results
- Monthly Realty Income is About to Get Bigger
- 3 Large Cap Dividend Challengers for Millennial Investors
- Sea Ltd Is On The Verge Of A 100% Rally, Should You Buy?
Want to see what other hedge funds are holding MDC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for M.D.C. Holdings, Inc. (NYSE:MDC – Get Rating).
Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.